BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23844750)

  • 1. Effects of Medicare Part D coverage gap on medication adherence.
    Zhang Y; Baik SH; Lave JR
    Am J Manag Care; 2013 Jun; 19(6):e214-24. PubMed ID: 23844750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure.
    Baik SH; Rollman BL; Reynolds CF; Lave JR; Smith KJ; Zhang Y
    J Ment Health Policy Econ; 2012 Sep; 15(3):105-18. PubMed ID: 23001279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression.
    Zhang Y; Baik SH; Zhou L; Reynolds CF; Lave JR
    Arch Gen Psychiatry; 2012 Jul; 69(7):672-9. PubMed ID: 22752233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes.
    Fung V; Mangione CM; Huang J; Turk N; Quiter ES; Schmittdiel JA; Hsu J
    Health Serv Res; 2010 Apr; 45(2):355-75. PubMed ID: 20050931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
    Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
    Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
    Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
    J Manag Care Spec Pharm; 2014 Aug; 20(8):862-76. PubMed ID: 25062080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs.
    Hsu J; Fung V; Price M; Huang J; Brand R; Hui R; Fireman B; Newhouse JP
    JAMA; 2008 Apr; 299(16):1929-36. PubMed ID: 18430912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic-only drug coverage in the Medicare Part D gap and effect on medication cost-cutting behaviors for patients with diabetes mellitus: the translating research into action for diabetes study.
    Duru OK; Mangione CM; Hsu J; Steers WN; Quiter E; Turk N; Ettner SL; Schmittdiel JA; Tseng CW
    J Am Geriatr Soc; 2010 May; 58(5):822-8. PubMed ID: 20406312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs.
    Jung K; McBean AM; Kim JA
    J Manag Care Pharm; 2012 Mar; 18(2):106-15. PubMed ID: 22380470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plans.
    Stuart B; Simoni-Wastila L; Yin X; Davidoff A; Zuckerman IH; Doshi J
    Med Care; 2011 May; 49(5):511-5. PubMed ID: 21422956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study.
    Safran DG; Strollo MK; Guterman S; Li A; Rogers WH; Neuman P
    J Gen Intern Med; 2010 Jan; 25(1):10-7. PubMed ID: 19882193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap.
    Polinski JM; Shrank WH; Huskamp HA; Glynn RJ; Liberman JN; Schneeweiss S
    PLoS Med; 2011 Aug; 8(8):e1001075. PubMed ID: 21857811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Race/Ethnicity, disability, and medication adherence among medicare beneficiaries with heart failure.
    Zhang Y; Baik SH
    J Gen Intern Med; 2014 Apr; 29(4):602-7. PubMed ID: 24366395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.
    Yala SM; Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF
    BMC Health Serv Res; 2014 Dec; 14():665. PubMed ID: 25526892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products.
    Zhang Y; Lave JR; Donohue JM; Fischer MA; Chernew ME; Newhouse JP
    Med Care; 2010 May; 48(5):409-17. PubMed ID: 20393360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan.
    Nair KV; Frech-Tamas F; Jan S; Wolfe P; Allen RR; Saseen JJ
    J Health Care Finance; 2011; 38(2):38-53. PubMed ID: 22372031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generic initiation and antidepressant therapy adherence under Medicare Part D.
    Bao Y; Ryan AM; Shao H; Pincus HA; Donohue JM
    Am J Manag Care; 2013 Dec; 19(12):989-98. PubMed ID: 24512035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare Part D coverage gap and diabetes beneficiaries.
    Schmittdiel JA; Ettner SL; Fung V; Huang J; Turk N; Quiter ES; Swain BE; Hsu JT; Mangione CM
    Am J Manag Care; 2009 Mar; 15(3):189-93. PubMed ID: 19298100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficiaries with cardiovascular disease and thePart D coverage gap.
    Polinski JM; Shrank WH; Glynn RJ; Huskamp HA; Roebuck MC; Schneeweiss S
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):387-95. PubMed ID: 22511746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.